Results 201 to 210 of about 33,909 (239)
Some of the next articles are maybe not open access.
Systemic Immunoglobulin Light-Chain Amyloidosis
Clinical Lymphoma and Myeloma, 2006Amyloidosis is a rare disease in which amyloid fibrils compromise organ function and lead to death. Systemic immunoglobulin light-chain amyloidosis, usually caused by free light chains (FLCs) made by clonal plasma cells, is the most frequent type. Hereditary and senile systemic amyloidosis are less frequent types.
openaire +2 more sources
Managing Systemic Light-Chain Amyloidosis
Journal of the National Comprehensive Cancer Network, 2007Amyloidosis is a rare disease in which a specific protein is deposited as aggregated interstitial fibrils that can compromise organ function and lead to death. Immunoglobulin (Ig) light-chain amyloidosis (AL), caused by the monoclonal gammopathy of a plasma cell dyscrasia, is the most common type.
openaire +2 more sources
Treatment of immunoglobulin light chain amyloidosis
Current Hematologic Malignancy Reports, 2009No therapy is uniformly effective in the management of immunoglobulin light chain amyloidosis (AL amyloidosis). Despite the common generalization, therapy is highly effective. Options available to patients with AL amyloidosis include high-dose therapy, but this is applicable to only about one fourth of patients.
Morie A, Gertz, Steven R, Zeldenrust
openaire +2 more sources
Equine light-chain-associated amyloidosis
Amyloid, 1996We have previously immunologically typed amyloid protein extracted from a horse with malignant histiolymtphocytic lymphosarcoma as immunoglobulin (Ig)-derived amylaid. In the present paper, the Ig character of the horse amyloid is confirmed by the amino acid sequence of the constituent protein.
Theodoor A. Niewold +4 more
openaire +1 more source
Amyloid Formation in Light Chain Amyloidosis
Current Topics in Medicinal Chemistry, 2013Light chain amyloidosis is one of the unique examples within amyloid diseases where the amyloidogenic precursor is a protein that escapes the quality control machinery and is secreted from the cells to be circulated in the bloodstream. The immunoglobulin light chains are produced by an abnormally proliferative monoclonal population of plasma cells that
openaire +2 more sources
[Amyloid light chain amyloidosis].
Brain and nerve = Shinkei kenkyu no shinpo, 2014Primary amyloid light chain (AL) amyloidosis is the most common and most aggressive form of systemic amyloidosis. In AL amyloidosis, the products of free light chains (FLCs) of monoclonal amyloidogenic plasma cells deposit in the heart, kidneys, liver, gastrointestinal tract, autonomic nerve systems, and soft tissues, consequently leading to ...
Kenshi, Suzuki, Toshiko, Shimizu
openaire +1 more source
Immunoglobulin Light Chain and Systemic Light-Chain Amyloidosis
2007Light-chain amyloidosis (AL) is characterized by the clonal expansion of plasma B cells that secrete large amounts of monoclonal immunoglobulin light chains. The free light chains circulate in serum and form amyloid fibrils on vital organs such as the kidney, heart, and liver causing organ failure and eventually death.
Marina Ramirez-Alvarado +5 more
openaire +1 more source
Planning for post‐pandemic cancer care delivery: Recovery or opportunity for redesign?
Ca-A Cancer Journal for Clinicians, 2021Pelin Cinar +2 more
exaly
The assembly, regulation and function of the mitochondrial respiratory chain
Nature Reviews Molecular Cell Biology, 2021Irene Vercellino, Leonid A Sazanov
exaly
Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back
Ca-A Cancer Journal for Clinicians, 2014Giada Bianchi
exaly